Oramed Pharmaceuticals Inc.
ORMP
$2.33
$0.031.30%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -12.41% | -18.70% | 1.69% | 14.87% | 4.06% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 140.41% | -28.83% | -30.69% | -64.79% | -61.34% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -11.91% | -18.74% | 1.52% | 14.14% | 3.48% |
|
|||||
Total Current Assets | -11.91% | -18.74% | 1.52% | 14.14% | 3.48% |
Net Property, Plant & Equipment | -29.04% | -28.80% | -25.52% | -24.58% | -13.04% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | -9.09% | 16.13% | 9.68% |
Total Assets | -29.60% | -28.50% | 17.85% | 27.46% | 36.44% |
|
|||||
Total Accounts Payable | 43.19% | 95.04% | 320.65% | -68.75% | -74.67% |
Total Accrued Expenses | 6.72% | -- | -- | 0.00% | -29.90% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -19.10% | -3.19% | 5.93% | 4.96% | 8.10% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -89.32% | -93.25% | 249.86% | 574.90% | 826.11% |
|
|||||
Total Current Liabilities | -89.32% | -93.25% | 249.86% | 574.90% | 826.11% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -54.39% | -52.19% | -51.64% | -51.77% | -47.14% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -0.29% | 0.02% | -0.10% | 0.17% | 0.22% |
Total Liabilities | -82.78% | -88.44% | 42.59% | 293.80% | 449.86% |
|
|||||
Common Stock & APIC | 0.47% | 0.89% | 1.46% | 1.64% | 2.06% |
Retained Earnings | -12.10% | 2.61% | 12.44% | 6.28% | 3.39% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -10.72% | 4.90% | 16.84% | 10.38% | 7.91% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -10.72% | 4.90% | 16.84% | 10.38% | 7.91% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 1.08% | -1.88% | -2.24% | -11.68% | -41.46% |
Total Equity | -10.77% | 4.92% | 16.93% | 10.37% | 7.76% |
|